Extracellular matrix remodeling may predominate over hepatocyte injury in hepatocellular carcinoma development

Oncology Reports

Volumn 10, Issue 4, 2003, Pages 957-962

  Yoshiji, Hitoshi ^a   Kuriyama, Shigeki ^b   Yoshii, Junichi ^a   Ikenaka, Yasuhide ^a   Noguchi, Ryuichi ^a   Yanase, Koji ^a   Namisaki, Tadashi ^a   Yamazaki, Masaharu ^a   Tsujinoue, Hirohisa ^a   Imazu, Hiroo ^a   Fukui, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Extracellular matrix; Hepatocarcinogenesis; Hepatocyte injury; Herbal medicine; Liver fibrosis

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; GLUTATHIONE TRANSFERASE; HERBACEOUS AGENT; HYDROXYPROLINE; MESSENGER RNA; SAIKO-KEISHI-TO; SHOSAIKO-TO; SHOSAIKOTO GO KEISHIKASHAKUYAKUTO; XIAO CHAI HU TANG;

ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; DIET; DRUG EFFECT; ENZYMOLOGY; EXTRACELLULAR MATRIX; FISCHER 344 RAT; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PRECANCER; RAT; VITAMIN DEFICIENCY;

AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CHOLINE DEFICIENCY; DIET; DRUGS, CHINESE HERBAL; EXTRACELLULAR MATRIX; GLUTATHIONE TRANSFERASE; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; RNA, MESSENGER;

EID: 1542787540     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.4.957     Document Type: Article

References (35)

1. Schafer DF and Sorrell MF: Hepatocellular carcinoma. Lancet 353: 1253-1257, 1999. (Pubitemid 29168472)
2. Simonetti RG, Camma C, Fiorello F, et al: Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 36: 962-972, 1991.
3. Akriviadis EA, Llovet JM, Efremidis SC, et al: Hepatocellular carcinoma. Br J Surg 85: 1319-1331, 1998. (Pubitemid 28468331)
4. Johnson PJ and Williams R: Cirrhosis and the aetiology of hepatocellular carcinoma. J Hepatol 4: 140-147, 1987.
5. Slaga TJ and Scribner JD: Inhibition of tumor initiation and promotion by anti-inflammatory agents. J Natl Cancer Inst 51: 1723-1725, 1973.
6. Marks F: Hyperplastic transformation and tumor promotion in mouse epidermis: possible consequences of disturbance of endogeneous mechanism controlling proliferation and differentiation. Carcinogenesis 2: 97-116, 1978.
7. Tarao K, Rino Y, Ohkawa S, et al: Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 86: 589-595, 1999. (Pubitemid 29379404)
8. Tarao K, Takemiya S, Tamai S, et al: Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer 79: 688-694, 1997. (Pubitemid 27076334)
9. Boudreau N and Bisseil MJ: Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10: 640-646, 1998. (Pubitemid 28477023)
10. Theret N, Musso O, Turlin B, et al: Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 34: 82-88, 2001. (Pubitemid 32591486)
11. Seeff LB: Natural history of hepatitis C. Hepatology 26: 21S-28S, 1997.
12. Benvegnu L and Alberti A: Risk factors and prevention of hepatocellular carcinoma in HCV infection. Dig Dis Sci 41: 49S-55S, 1996. (Pubitemid 27041818)
13. Sakaida I, Hironaka K, Uchida K, et al: Fibrosis accelerates the development of enzyme-altered lesions in the rat liver. Hepatology 28: 1247-1252, 1998. (Pubitemid 28493834)
14. Nakae D, Yoshiji H, Mizumoto Y, et al: High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats. Cancer Res 52: 5042-5045, 1992.
15. Mizumoto Y, Nakae D, Yoshiji H, et al: Inhibitory effects of 2-O-octadecylascorbic acid and other vitamin C and E derivatives on the induction of enzyme-altered putative preneoplastic lesions in the livers of rats fed a choline-deficient, L-amino acid-defined diet. Carcinogenesis 15: 241-246, 1994.
16. Tamura K, Nakae D, Horiguchi K, et al: Inhibition by N-(4-hydroxyphenyl) retinamide and all-trans-retinoic acid of exogenous and endogenous development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in the livers of rats. Carcinogenesis 18: 2133-2141, 1997. (Pubitemid 28134740)
17. Sakaida I, Matsumura Y, Akiyama S, et al: Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J Hepatol 28: 298-306, 1998. (Pubitemid 28116438)
18. Sakaida I, Matsumura Y, Kubota M, et al: The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. Hepatology 23: 755-763, 1996. (Pubitemid 26111989)
19. Okada K, Hasegawa R, Haranaka R, et al: Effects of saiko-keishi-to on the metabolism of glutathione in D-galactosamine-induced hepatic injury. Nihon Univ J Med 37: 193-202, 1997.
20. Kayano K, Sakaida I, Uchida K, et al: Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells. J Hepatol 29: 642-649, 1998. (Pubitemid 28484955)
21. Yoshiji H, Kuriyama S, Yoshii J, et al: Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34: 745-750, 2001. (Pubitemid 32927999)
22. Yoshiji H, Nakae D, Mizumoto Y, et al: Inhibitory effect of dietary iron deficiency on inductions of putative preneoplastic lesions as well as 8-hydroxydeoxyguanosine in DNA and lipid peroxidation in the livers of rats caused by exposure to a choline-deficient L-amino acid defined diet. Carcinogenesis 13: 1227-1233, 1992.
23. Yoshiji H, Kuriyama S, Miyamoto Y, et al: Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32: 1248-1254, 2000.
24. Shimizu I, Ma YR, Mizobuchi Y, et al: Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29: 149-160, 1999. (Pubitemid 29023997)
25. Nagao M, Nakajima Y, Kanehiro H, et al: The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma. Hepatology 32: 491-500, 2000.
26. Friedman SL: Cytokines and fibrogenesis. Semin Liver Dis 19: 129-140, 1999.
27. Gish RG and Mason A: Autoimmune liver disease. Current standards, future directions. Clin Liver Dis 5: 287-314, 2001. (Pubitemid 32472560)
28. Moriya K, Fujie H, Shintani Y, et al: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4: 1065-1067, 1998. (Pubitemid 28417341)
29. Senger DR, Brown LF, Claffey KP, et al: Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion Metastasis 14: 385-394, 1994.
30. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
31. Bolontrade MF, Stern MC, Binder RL, et al: Angiogenesis is an early event in the development of chemically induced skin tumors. Carcinogenesis 19: 2107-2113, 1998. (Pubitemid 29010248)
32. Bergers G, Javaherian K, Lo KM, et al: Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284: 808-812, 1999. (Pubitemid 29291347)
33. Ohta Y, Nishida K, Sasaki E, et al: Comparative study of oral and parenteral administration of sho-saiko-to (xiao-chaihu-tang) extract on D-galactosamine-induced liver injury in rats. Am J Chin Med 25: 333-342, 1997. (Pubitemid 127757864)
34. Tatsuta M, Iishi H, Baba M, et al: Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by Nnitrosomorpholine in Sprague-Dawley rats. Jpn J Cancer Res 82: 987-992, 1991.
35. Tatsuta M, Iishi H, Baba M, et al: Suppression by Chai-hu-gui-zhi-tang of the development of liver lesions induced by N-nitrosomorpholine in Sprague-Dawley rats. Cancer Lett 152: 31-36, 2000. (Pubitemid 30169015)